Insider Transactions in Q3 2024 at Kiora Pharmaceuticals Inc (KPRX)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 11
2024
|
Carmine N. Stengone Director |
BUY
Open market or private purchase
|
Direct |
1,250
+50.0%
|
$3,750
$3.68 P/Share
|
Sep 10
2024
|
Aron Shapiro Director |
BUY
Open market or private purchase
|
Indirect |
3,000
+50.0%
|
$9,000
$3.6 P/Share
|
Aug 19
2024
|
Lisa Walters Hoffert Director |
BUY
Open market or private purchase
|
Direct |
1,250
+50.0%
|
$3,750
$3.86 P/Share
|
Aug 19
2024
|
Praveen Tyle Director |
BUY
Open market or private purchase
|
Direct |
5,000
+49.93%
|
$15,000
$3.96 P/Share
|
Aug 14
2024
|
Melissa Tosca CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+12.82%
|
$6,000
$3.21 P/Share
|
Jul 01
2024
|
Eric Joseph Daniels Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,355
+28.36%
|
-
|
Jul 01
2024
|
Melissa Tosca CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,620
+39.65%
|
-
|
Jul 01
2024
|
Brian M. Strem President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,629
+34.13%
|
-
|